Differential organ phenotypes after postnatal Igf1r gene conditional deletion induced by tamoxifen in UBC-CreERT2; Igf1r fl/fl double transgenic mice

Transgenic Research

Volumn 24, Issue 2, 2015, Pages 279-294

  López, Icíar Paula ^a   Rodriguez de la Rosa, Lourdes ^b,c,d   Pais, Rosete Sofia ^a   Piñeiro Hermida, Sergio ^a   Torrens, Raquel ^a   Contreras, Julio ^b,c,e   Varela Nieto, Isabel ^b,c,d   Pichel, José García ^a  

^a CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cochlea; Cre lox system; IGF1R; Lung; Transgenic mouse; UBC CreERT2 mice

Indexed keywords

CRE RECOMBINASE; INTEGRASE; MESSENGER RNA; SOMATOMEDIN C RECEPTOR; TAMOXIFEN;

ANIMAL; BIOSYNTHESIS; BODY WEIGHT; DRUG EFFECTS; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART; HUMAN; MALE; MOUSE; ORGAN SIZE; SPERMATOGENESIS; SPLEEN; TESTIS; TRANSGENIC MOUSE;

ANIMALS; BODY WEIGHT; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HUMANS; INTEGRASES; MALE; MICE; MICE, TRANSGENIC; ORGAN SIZE; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; SPERMATOGENESIS; SPLEEN; TAMOXIFEN; TESTIS;

EID: 84937792141     PISSN: 09628819     EISSN: 15739368     Source Type: Journal    
DOI: 10.1007/s11248-014-9837-5     Document Type: Article

References (64)

1. Abbas A et al (2011) The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium. Diabetes 60:2169–2178. doi:10.2337/db11-0197
2. Abuzzahab MJ et al (2003) IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349:2211–2222. doi:10.1056/NEJMoa010107
3. Annunziata M, Granata R, Ghigo E (2011) The IGF system. Acta Diabetol 48:1–9. doi:10.1007/s00592-010-0227-z
4. Baker J, Liu JP, Robertson EJ, Efstratiadis A (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73–82
5. Birling MC, Gofflot F, Warot X (2009) Site-specific recombinases for manipulation of the mouse genome. Methods Mol Biol 561:245–263. doi:10.1007/978-1-60327-019-9_16
6. Bonnette SG, Hadsell DL (2001) Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology 142:4937–4945. doi:10.1210/endo.142.11.8500
7. Boucher J et al (2012) Impaired thermogenesis and adipose tissue development in mice with fat-specific disruption of insulin and IGF-1 signalling. Nat Commun 3:902. doi:10.1038/ncomms1905
8. Cadoret A et al (2005) c-myc-induced hepatocarcinogenesis in the absence of IGF-I receptor. Int J Cancer 114:668–672. doi:10.1002/ijc.20805
9. Camarero G et al (2001) Delayed inner ear maturation and neuronal loss in postnatal Igf-1-deficient mice. J Neurosci 21:7630–7641
10. Corvaia N, Beck A, Caussanel V, Goetsch L (2013) Insulin-like growth factor receptor type I as a target for cancer therapy. Front Biosci (Schol Ed) 5:439–450
11. Desbois-Mouthon C et al (2006) Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout. FASEB J 20:773–775. doi:10.1096/fj.05-4704fje
12. Dietrich P, Dragatsis I, Xuan S, Zeitlin S, Efstratiadis A (2000) Conditional mutagenesis in mice with heat shock promoter-driven cre transgenes. Mamm Genome 11:196–205
13. DiGirolamo DJ, Mukherjee A, Fulzele K, Gan Y, Cao X, Frank SJ, Clemens TL (2007) Mode of growth hormone action in osteoblasts. J Biol Chem 282:31666–31674. doi:10.1074/jbc.M705219200
14. Dinchuk JE et al (2010) Insulin receptor (IR) pathway hyperactivity in IGF-IR null cells and suppression of downstream growth signaling using the dual IGF-IR/IR inhibitor, BMS-754807. Endocrinology 151:4123–4132. doi:10.1210/en.2010-0032
15. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495–516. doi:10.1080/01926230701320337
16. Epaud R et al (2012) Knockout of insulin-like growth factor-1 receptor impairs distal lung morphogenesis. PLoS ONE 7:e48071. doi:10.1371/journal.pone.0048071
17. Feil R (2007) Conditional somatic mutagenesis in the mouse using site-specific recombinases. Handb Exp Pharmacol 178:3–28. doi:10.1007/978-3-540-35109-2_1
18. Feil R, Wagner J, Metzger D, Chambon P (1997) Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237:752–757. doi:10.1006/bbrc.1997.7124
19. Feil S, Valtcheva N, Feil R (2009) Inducible Cre mice. Methods Mol Biol 530:343–363. doi:10.1007/978-1-59745-471-1_18
20. Fernandez-Moreno C, Pichel JG, Chesnokova V, De Pablo F (2004) Increased leptin and white adipose tissue hypoplasia are sexually dimorphic in Lif null/Igf-I haploinsufficient mice. FEBS Lett 557:64–68
21. Froment P et al (2007) Inactivation of the IGF-I receptor gene in primary Sertoli cells highlights the autocrine effects of IGF-I. J Endocrinol 194:557–568. doi:10.1677/JOE-07-0258
22. Girnita L, Worrall C, Takahashi SI, Seregard S, Girnita A (2013) Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation. Cell Mol Life Sci 71:2403–2427. doi:10.1007/s00018-013-1514-y
23. Holzenberger M, Leneuve P, Hamard G, Ducos B, Perin L, Binoux M, Le Bouc Y (2000) A targeted partial invalidation of the insulin-like growth factor I receptor gene in mice causes a postnatal growth deficit. Endocrinology 141:2557–2566
24. Holzenberger M et al (2001) Experimental IGF-I receptor deficiency generates a sexually dimorphic pattern of organ-specific growth deficits in mice, affecting fat tissue in particular. Endocrinology 142:4469–4478. doi:10.1210/endo.142.10.8461
25. Ikeno M, Suzuki N, Kamiya M, Takahashi Y, Kudoh J, Okazaki T (2012) LINE1 family member is negative regulator of HLA-G expression. Nucl Acids Res 40:10742–10752. doi:10.1093/nar/gks874
26. Kappeler L et al (2008) Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism. PLoS Biol 6:e254. doi:10.1371/journal.pbio.0060254
27. Kellendonk C, Tronche F, Casanova E, Anlag K, Opherk C, Schütz G (1999) Inducible site-specific recombination in the brain. J Mol Biol 285:175–182. doi:10.1006/jmbi.1998.2307
28. Kloting N et al (2008) Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth. Diabetes 57:2074–2082. doi:10.2337/db07-1538
29. Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M, Kahn CR (2003) Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest 111:1835–1842. doi:10.1172/JCI17455
30. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR (2002) β-Cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet 31:111–115. doi:10.1038/ng872
31. LeRoith D, Roberts CT Jr (2003) The insulin-like growth factor system and cancer. Cancer Lett 195:127–137
32. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59–72
33. Liu Q, Li MZ, Leibham D, Cortez D, Elledge SJ (1998) The univector plasmid-fusion system, a method for rapid construction of recombinant DNA without restriction enzymes. Curr Biol 8:S1300–S1301. doi:10.1016/S0960-9822(07)00560-X
34. Mason JL, Xuan S, Dragatsis I, Efstratiadis A, Goldman JE (2003) Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J Neurosci 23:7710–7718
35. Moreno-Barriuso N, Lopez-Malpartida AV, de Pablo F, Pichel JG (2006) Alterations in alveolar epithelium differentiation and vasculogenesis in lungs of LIF/IGF-I double deficient embryos. Dev Dyn 235:2040–2050. doi:10.1002/dvdy.20842
36. Morrisey EE, Hogan BL (2010) Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell 18:8–23. doi:10.1016/j.devcel.2009.12.010
37. Muller K et al (2011) TSH compensates thyroid-specific IGF-I receptor knockout and causes papillary thyroid hyperplasia. Mol Endocrinol 25:1867–1879. doi:10.1210/me.2011-0065
38. Nef S, Verma-Kurvari S, Merenmies J, Vassalli J-D, Efstratiadis A, Accili D, Parada LF (2003) Testis determination requires insulin receptor family function in mice. Nature 426:291–295
39. Ock S et al (2013) IGF-1 receptor deficiency in thyrocytes impairs thyroid hormone secretion and completely inhibits TSH-stimulated goiter. FASEB J 27:4899–4908. doi:10.1096/fj.13-231381
40. Okano T, Xuan S, Kelley MW (2011) Insulin-like growth factor signaling regulates the timing of sensory cell differentiation in the mouse cochlea. J Neurosci 31:18104–18118. doi:10.1523/JNEUROSCI.3619-11.2011
41. Pais RS, Moreno-Barriuso N, Hernández-Porras I, López IP, De Las Rivas J, Pichel JG (2013) Transcriptome analysis in prenatal IGF1-deficient mice identifies molecular pathways and target genes involved in distal lung differentiation. PLoS ONE 8:e83028. doi:10.1371/journal.pone.0083028
42. Pichel JG, Fernandez-Moreno C, Vicario-Abejon C, Testillano PS, Patterson PH, de Pablo F (2003) Developmental cooperation of leukemia inhibitory factor and insulin-like growth factor I in mice is tissue-specific and essential for lung maturation involving the transcription factors Sp3 and TTF-1. Mech Dev 120:349–361
43. Pitetti JL et al (2013) An essential role for insulin and IGF1 receptors in regulating sertoli cell proliferation, testis size, and FSH action in mice. Mol Endocrinol 27:814–827. doi:10.1210/me.2012-1258
44. Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8:915–928. doi:10.1038/nrc2536
45. Raile K et al (2006) Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor I receptor (IGF1R) mutation: implications for a gene dosage effect of the human IGF1R. J Clin Endocrinol Metab 91:2264–2271. doi:10.1210/jc.2005-2146
46. Riquelme R et al (2010) A comparative study of age-related hearing loss in wild type and insulin-like growth factor I deficient mice. Front Neuroanat 4:27–39. doi:10.3389/fnana.2010.00027
47. Roback EW, Barakat AJ, Dev VG, Mbikay M, Chretien M, Butler MG (1991) An infant with deletion of the distal long arm of chromosome 15 (q26.1—qter) and loss of insulin-like growth factor 1 receptor gene. Am J Med Genet 38:74–79. doi:10.1002/ajmg.1320380117
48. Ruzankina Y et al (2007) Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 1:113–126. doi:10.1016/j.stem.2007.03.002
49. Sanchez-Calderon H, Rodriguez-de la Rosa L, Milo M, Pichel JG, Holley M, Varela-Nieto I (2010) RNA microarray analysis in prenatal mouse cochlea reveals novel IGF-I target genes: implication of MEF2 and FOXM1 transcription factors. PLoS ONE 5:e8699. doi:10.1371/journal.pone.0008699
50. Scolnick JA, Cui K, Duggan CD, Xuan S, Yuan X-B, Efstratiadis A, Ngai J (2008) Role of IGF signaling in olfactory sensory map formation and axon guidance. Neuron 57:847–857. doi:10.1016/j.neuron.2008.01.027
51. Skarnes WC et al (2011) A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474:337–342. doi:10.1038/nature10163
52. Sutherland BW, Knoblaugh SE, Kaplan-Lefko PJ, Wang F, Holzenberger M, Greenberg NM (2008) Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium. Cancer Res 68:3495–3504. doi:10.1158/0008-5472.CAN-07-6531
53. Varela-Nieto I, Murillo-Cuesta S, Rodriguez-de la Rosa L, Lassatetta L, Contreras J (2013) IGF-I deficiency and hearing loss: molecular clues and clinical implications. Pediatr Endocrinol Rev 10:460–472
54. Vooijs M, Jonkers J, Berns A (2001) A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep 2:292–297. doi:10.1093/embo-reports/kve064
55. Walenkamp MJ et al (2005) Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab 90:2855–2864. doi:10.1210/jc.2004-1254
56. Walenkamp MJ et al (2008) Successful long-term growth hormone therapy in a girl with haploinsufficiency of the insulin-like growth factor-I receptor due to a terminal 15q26.2->qter deletion detected by multiplex ligation probe amplification. J Clin Endocrinol Metab 93:2421–2425. doi:10.1210/jc.2007-1789
57. Wang J, Zhou J, Powell-Braxton L, Bondy C (1999) Effects of Igf1 gene deletion on postnatal growth patterns. Endocrinology 140:3391–3394
58. Werner H, Bruchim I (2009) The insulin-like growth factor-I receptor as an oncogene. Arch Physiol Biochem 115:58–71. doi:10.1080/13813450902783106
59. White LE, Santora RJ, Cui Y, Moore FA, Hassoun HT (2012) TNFR1-dependent pulmonary apoptosis during ischemic acute kidney injury. Am J Physiol Lung Cell Mol Physiol 303:L449–L459. doi:10.1152/ajplung.00301.2011
60. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF (1999) Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet 23:32–40. doi:10.1038/12631
61. Xuan S, Szabolcs M, Cinti F, Perincheri S, Accili D, Efstratiadis A (2010) Genetic analysis of type-1 insulin-like growth factor receptor signaling through insulin receptor substrate-1 and -2 in pancreatic beta cells. J Biol Chem 285:41044–41050. doi:10.1074/jbc.M110.144790
62. Zeger M et al (2007) Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination. Glia 55:400–411. doi:10.1002/glia.20469
63. Zhang L, Wang XH, Wang H, Du J, Mitch WE (2010) Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy. J Am Soc Nephrol 21:419–427. doi:10.1681/ASN.2009060571
64. Zhu M, Ji G, Jin G, Yuan Z (2009) Different responsiveness to a high-fat/cholesterol diet in two inbred mice and underlying genetic factors: a whole genome microarray analysis. Nutr Metab 6:43